Bridgefront Capital »

Beam Therapeutics shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $811k 34k 23.83
2024-06-30 $322k 14k 23.43

More positions owned by Bridgefront Capital

Take-Two Interactive Software (TTWO)
TPG Com Cl A (TPG)
Constellation Brands Cl A (STZ)
Broadcom (AVGO)
Encana Corporation (OVV)
Kimberly-Clark Corporation (KMB)
Clorox Company (CLX)
Lamb Weston Hldgs (LW)
Keysight Technologies (KEYS)
EQT Corporation (EQT)
Celsius Hldgs Com New (CELH)
Amgen (AMGN)
Micron Technology (MU)
Host Hotels & Resorts (HST)
Agree Realty Corporation (ADC)

View all positions for Bridgefront Capital

Top funds holding Beam Therapeutics

FMR
ARK Investment Management
Farallon Capital Management
BlackRock
State Street Corporation
Vanguard Portfolio Management
Arch Venture Corp
Vanguard Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Kynam Capital Management
Geode Capital Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas
ADAR1 Capital Management

View all funds holding Beam Therapeutics